Nationwide quality improvement in lung cancer care: The role of the Danish Lung Cancer Group and Registry

Journal of Thoracic Oncology

Volumn 8, Issue 10, 2013, Pages 1238-1247

  Jakobsen, Erik ^a,b   Green, Anders ^b   Oesterlind, Kell ^c   Rasmussen, Torben Riis ^d   Iachina, Maria ^a   Palshof, Torben ^d  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c Mental Health Services CPH   (Denmark)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Indicators; Lung Cancer; Monitoring; Outcome measurement; Prognosis; Quality; Quality of care; Survival

Indexed keywords

ARTICLE; CANCER CENTER; CANCER PATIENT; CANCER PROGNOSIS; CANCER REGISTRY; CANCER RESEARCH; CANCER STAGING; DENMARK; HEALTH CARE QUALITY; HUMAN; LUNG CANCER; MEDICAL SOCIETY; OVERALL SURVIVAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; TOTAL QUALITY MANAGEMENT;

COMBINED MODALITY THERAPY; DELIVERY OF HEALTH CARE; DENMARK; FOLLOW-UP STUDIES; GUIDELINE ADHERENCE; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; QUALITY IMPROVEMENT; QUALITY INDICATORS, HEALTH CARE; QUALITY OF HEALTH CARE; REGISTRIES; SURVIVAL RATE;

EID: 84892403959     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3182a4070f     Document Type: Article

References (66)

1. Tulinius H, Storm HH, Pukkala E, et al. Cancer in the Nordic countries, 1981-86. A joint publication of the five Nordic Cancer Registries. Acta Pathol Microbiol Immunol Scand 1992;100:1-94.
2. Hansen J, Olsen JH. Survival of Danish cancer patients 1943-1987. Respiratory system. Acta Pathol Microbiol Immunol Scand 1993;33:77-98.
3. Andersen KB. Lung cancer-better prognosis? Ugeskr Laeger 1994;156:4719-20.
4. Engeland A, Bjorge T, Haldorsen T, et al. Prognosis of patients with lung cancer diagnosed in Norway, 1954-93. Cancer Causes Control 1998;9:57-65.
5. Mainz J, Krog BR, Bjørnshave B, Bartels P. Nationwide continuous quality improvement using clinical indicators: the Danish National Indicator Project. Int J Qual Health Care 2004;16(Suppl 1):i45-i50.
6. Donabedian A. Evaluation the quality of medical care. Milbank Mem Fund 1966;44:166-206.
7. Brook RH, Davies-Avery A, Greenfield S, et al. Assessing the quality of medical care using outcome measures: an overview of the method. Med Care 1977;15(9 Suppl):suppl 1-supp165.
8. Mainz J. Developing evidence-based clinical indicators: a state of the art methods primer. Int J Qual Health Care 2003;15:5-11
9. Mainz J. Defining and classifying clinical indicators for quality improvement. Int J Qual Health Care 2003;15:523-530.
10. Butler CA, Darragh KM, Currie GP, Anderson WJ. Variation in lung cancer survival rates between countries: do differences in data reporting contribute? Respir Med 2006;100:1642-1646.
11. Robinson D, Sankila R, Hakulinen T, Møller H. Interpreting international comparisons of cancer survival: the effects of incomplete registration and the presence of death certificate only cases on survival estimates. Eur J Cancer 2007;43:909-913.
12. Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010;46:765-781.
13. Verdecchia A, Guzzinati S, Francisci S, et al; EUROCARE Working Group. Survival trends in European cancer patients diagnosed from 1988 to 1999. Eur J Cancer 2009;45:1042-1066.
14. Berrino F, De AR, Sant M, et al. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. Lancet Oncol 2007;8:773-783.
15. Janssen-Heijnen ML, Coebergh JW. The changing epidemiology of lung cancer in Europe. Lung Cancer 2003;41:245-258.
16. Hakulinen T, Engholm G, Gislum M, et al. Trends in the survival of patients diagnosed with cancers in the respiratory system in the Nordic countries 1964-2003 followed up to the end of 2006. Acta Oncol 2010;49:608-623.
17. Holmberg L, Sandin F, Bray F, et al. National comparisons of lung cancer survival in England, Norway and Sweden 2001-2004: differences occur early in follow-up. Thorax 2010;65:436-441.
18. Gregor A, Thomson CS, Brewster DH, et al; Scottish Cancer Trials Lung Group; Scottish Cancer Therapy Network. Management and survival of patients with lung cancer in Scotland diagnosed in 1995: results of a national population based study. Thorax 2001;56:212-217.
19. Pozet A, Westeel V, Berion P, et al. Rurality and survival differences in lung cancer: a large population-based multivariate analysis. Lung Cancer 2008;59:291-300.
20. Bossard N, Velten M, Remontet L, et al. Survival of cancer patients in France: a population-based study from The Association of the French Cancer Registries (FRANCIM). Eur J Cancer 2007;43:149-160.
21. de Cos JS, Miravet L, Abal J, et al. Lung cancer survival in Spain and prognostic factors: a prospective, multiregional study. Lung Cancer 2008;59:246-254.
22. Goldstraw P, Crowley J, Chansky K, et al; International Association for the Study of Lung Cancer International Staging Committee; Participating Institutions. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007;2:706-714.
23. Rami-Porta R, Crowley JJ, Goldstraw P. The revised TNM staging system for lung cancer. Ann Thorac Cardiovasc Surg 2009;15:4-9.
24. Lally BE, Urbanic JJ, Blackstock AW, Miller AA, Perry MC. Small cell lung cancer: have we made any progress over the last 25 years? Oncologist 2007;12:1096-1104.
25. Demedts IK, Vermaelen KY, van Meerbeeck JP. Treatment of extensivestage small cell lung carcinoma: current status and future prospects. Eur Respir J 2010;35:202-215.
26. Damhuis R, Coonar A, Plaisier P, et al. A case-mix model for monitoring of postoperative mortality after surgery for lung cancer. Lung Cancer 2006;51:123-129.
27. Freixinet JL, Julià-Serdà G, Rodríguez PM, et al; Bronchogenic Carcinoma Cooperative Group of the Spanish Society of Pneumology and Thoracic Surgery GCCB-S. Hospital volume: operative morbidity, mortality and survival in thoracotomy for lung cancer. A Spanish multicenter study of 2994 cases. Eur J Cardiothorac Surg 2006;29:20-25.
28. Boffa DJ, Allen MS, Grab JD, Gaissert HA, Harpole DH, Wright CD. Data from The Society of Thoracic Surgeons General Thoracic Surgery database: the surgical management of primary lung tumors. J Thorac Cardiovasc Surg 2008;135:247-254.
29. Jakobsen E, Palshof T, Osterlind K, Pilegaard H. Data from a national lung cancer registry contributes to improve outcome and quality of surgery: Danish results. Eur J Cardiothorac Surg 2009;35:348-52; discussion 352.
30. Cassivi SD, Allen MS, Vanderwaerdt GD, et al. Patient-centered quality indicators for pulmonary resection. Ann Thorac Surg 2008;86:927-932.
31. Bryant AS, Rudemiller K, Cerfolio RJ. The 30-versus 90-day operative mortality after pulmonary resection. Ann Thorac Surg 2010;89:1717-1722; discussion 1722.
32. Nagai K, Yoshida J, Nishimura M. Postoperative mortality in lung cancer patients. Ann Thorac Cardiovasc Surg 2007;13:373-377.
33. Strand TE, Rostad H, Møller B, Norstein J. Survival after resection for primary lung cancer: a population based study of 3211 resected patients. Thorax 2006;61:710-715.
34. Jensen AR, Mainz J, Overgaard J. Impact of delay on diagnosis and treatment of primary lung cancer. Acta Oncol 2002;41:147-152.
35. Olsson JK, Schultz EM, Gould MK. Timeliness of care in patients with lung cancer: a systematic review. Thorax 2009;64:749-756.
36. Risberg T, Sørbye SW, Norum J, Wist EA. Diagnostic delay causes more psychological distress in female than in male cancer patients. Anticancer Res 1996;16:995-999.
37. Friberg S, Mattson S. On the growth rates of human malignant tumors: implications for medical decision making. J Surg Oncol 1997;65:284-297.
38. Comber H, Cronin DP, Deady S, Lorcain PO, Riordan P. Delays in treatment in the cancer services: impact on cancer stage and survival. Ir Med J 2005;98:238-239.
39. Yilmaz A, Damadoglu E, Salturk C, Okur E, Tuncer LY, Halezeroglu S. Delays in the diagnosis and treatment of primary lung cancer: are longer delays associated with advanced pathological stage? Ups J Med Sci 2008;113:287-296.
40. Christensen ED, Harvald T, Jendresen M, Aggestrup S, Petterson G. The impact of delayed diagnosis of lung cancer on the stage at the time of operation. Eur J Cardiothorac Surg 1997;12:880-884.
41. Aragoneses FG, Moreno N, Leon P, Fontan EG, Folque E; Bronchogenic Carcinoma Cooperative Group of the Spanish Society of Pneumology and Thoracic Surgery (GCCB-S). Influence of delays on survival in the surgical treatment of bronchogenic carcinoma. Lung Cancer 2002;36:59-63.
42. Quarterman RL, McMillan A, Ratcliffe MB, Block MI. Effect of preoperative delay on prognosis for patients with early stage non-small cell lung cancer. J Thorac Cardiovasc Surg 2003;125:108-113; discussion 113.
43. O'Rourke N, Edwards R. Lung cancer treatment waiting times and tumour growth. Clin Oncol (R Coll Radiol) 2000;12:141-144.
44. Fernando HC, Goldstraw P. The accuracy of clinical evaluative intrathoracic staging in lung cancer as assessed by postsurgical pathologic staging. Cancer 1990;65:2503-2506.
45. Cetinkaya E, Turna A, Yildiz P, et al. Comparison of clinical and surgicalpathologic staging of the patients with non-small cell lung carcinoma. Eur J Cardiothorac Surg 2002;22:1000-1005.
46. López-Encuentra A, García-Luján R, Rivas JJ, Rodríguez-Rodríguez J, Torres-Lanza J, Varela-Simo G; Bronchogenic Carcinoma Cooperative Group of the Spanish Society of Pneumology and Thoracic Surgery. Comparison between clinical and pathologic staging in 2,994 cases of lung cancer. Ann Thorac Surg 2005;79:974-979; discussion 979.
47. D'Cunha J, Herndon JE 2nd, Herzan DL, et al; Cancer and Leukemia Group B. Poor correspondence between clinical and pathologic staging in stage 1 non-small cell lung cancer: results from CALGB 9761, a prospective trial. Lung Cancer 2005;48:241-246.
48. Stiles BM, Servais EL, Lee PC, Port JL, Paul S, Altorki NK. Point: clinical stage IA non-small cell lung cancer determined by computed tomography and positron emission tomography is frequently not pathologic IA non-small cell lung cancer: the problem of understaging. J Thorac Cardiovasc Surg 2009;137:13-19.
49. Maziak DE, Darling GE, Inculet RI, et al. Positron emission tomography in staging early lung cancer: a randomized trial. Ann Intern Med 2009;151:221-248.
50. Macia I, Moya J, Escobar I, et al. Quality study of a lung cancer committee: study of agreement between preoperative and pathological staging. Eur J Cardiothorac Surg 2010;37:540-545.
51. Muehling B, Wehrmann C, Oberhuber A, Schelzig H, Barth T, Orend KH. Comparison of clinical and surgical-pathological staging in IIIA nonsmall cell lung cancer patients. Ann Surg Oncol 2012;19:89-93.
52. Martin-Ucar AE, Waller DA, Atkins JL, Swinson D, O'Byrne KJ, Peake MD. The beneficial effects of specialist thoracic surgery on the resection rate for non-small-cell lung cancer. Lung Cancer 2004;46:227-232.
53. Li WW, Visser O, Ubbink DT, Klomp HM, Kloek JJ, de Mol BA. The influence of provider characteristics on resection rates and survival in patients with localized non-small cell lung cancer. Lung Cancer 2008;60:441-451.
54. Damhuis RA, Schütte PR. Resection rates and postoperative mortality in 7,899 patients with lung cancer. Eur Respir J 1996;9:7-10.
55. Little AG, Rusch VW, Bonner JA, et al. Patterns of surgical care of lung cancer patients. Ann Thorac Surg 2005;80:2051-2056; discussion 2056.
56. Laroche C, Wells F, Coulden R, et al. Improving surgical resection rate in lung cancer. Thorax 1998;53:445-449.
57. Beattie G, Bannon F, McGuigan J. Lung cancer resection rates have increased significantly in females during a 15-year period. Eur J Cardiothorac Surg 2010;38:484-490.
58. Coory M, White WM, Johnson KS, et al. Systematic review of quality improvement interventions directed at cancer specialists. J Clin Oncol 2013;31:1583-1591.
59. Mainz J, Hansen A, Palshof T, Bartels PD. National quality measurement using clinical indicators: the National Indicator Project. J Surg Oncol 2009;99:500-504
60. Handy JR Jr. Attributes contributing to superior outcomes in the surgical management of early-stage lung cancer and examples of implementing improvement. Cancer J 2011;17:57-62.
61. Kerr EA, Fleming B. Making performance indicators work: experiences of US Veterans Health Administration. BMJ 2007;335:971-973.
62. Lennes IT, Lynch TJ. Quality indicators in cancer care: development and implementation for improved health outcomes in non-small-cell lung cancer. Clin Lung Cancer 2009;10:341-346.
63. Mainz J. Quality measurement can improve the quality of care-when supervised by health professionals. Editorial. Acta Psychiatr Scand 2008;117:321-322
64. Numan RC, Klomp HM, Li W, et al. A clinical audit in a multidisciplinary care path for thoracic surgery: an instrument for continuous quality improvement. Lung Cancer 2012;78:270-275.
65. Ouwens M, Hernens R, Termeer R, et al. Quality of integrated care for patients with non-small cell lung cancer. Cancer 2007;110:1782-1790
66. Tanvetyanon T. Quality-of-care indicators for non-small cell lung cancer. Cancer Control 2009;16:335-341.